Other languages Immatics N.V.

Equities

IMTX

NL0015285941

Real-time Estimate Cboe BZX Other stock markets 03:56:00 2024-06-06 pm EDT			5-day change	1st Jan Change
13.43 ^USD	-0.07%		+18.79%	+27.26%

May. 15	Mizuho Raises Immatics' Price Target to $16 From $14, Keeps Buy Rating	MT
May. 14	Immatics' Q1 Loss Narrows. Revenue Rises	MT

Other languages

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Immatics' Q1 Loss Narrows. Revenue Rises	May. 14
Immatics N.V. Reports Earnings Results for the First Quarter Ended March 31, 2024	May. 13
Sector Update: Health Care Stocks Gain Pre-Bell Thursday	Mar. 21
Sector Update: Health Care	Mar. 21
Immatics Swings to 2023 Net Loss, Revenue Falls -- Shares Down Pre-Bell	Mar. 21
Immatics N.V. Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 21
Sector Update: Health Care Stocks Mixed Premarket Thursday	Jan. 18
Immatics Prices $175 Million Share Offering	Jan. 18
Immatics Plans Common Stock Offering	Jan. 17
Immatics N.V. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 14
Immatics N.V. Reports Interim Clinical Data from ACTengine IMA203 and IMA203CD8 TCR-T Monotherapies Targeting PRame in an Ongoing Phase 1 Trial	Nov. 08
Immatics' IMA203 TCR-T Program Receives Regenerative Medicine Advanced Therapy Designation	23-10-24
Immatics N.V. Receives FDA Regenerative Medicine Advanced Therapy Designation for ACTengine(R) IMA203 TCR-T Monotherapy	23-10-24
Aktien New York Schluss: Weitere Gewinne nach jüngstem Rücksetzer	23-09-11
Aktien New York: Weitere Gewinne nach jüngstem Rücksetzer	23-09-11
Moderna se asocia con Immatics para impulsar el desarrollo de vacunas contra el cáncer	23-09-11
Moderna : collaboration stratégique avec Immatics	23-09-11
Moderna und Immatics schmieden Milliardendeal für Krebsmedikamente	23-09-11
Moderna, Immatics to Collaborate to Develop Novel Cancer Therapies	23-09-11
Moderna intensifica sus esfuerzos contra el cáncer con una nueva asociación -- Market Talk	23-09-11

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Immatics N.V.

Equities

IMTX

NL0015285941

Other languages

Filters